272 related articles for article (PubMed ID: 33347014)
1. Comparison of Surgical Site Infection Risk Between Warfarin, LMWH, and Aspirin for Venous Thromboprophylaxis in TKA or THA: A Systematic Review and Meta-Analysis.
Hughes LD; Lum J; Mahfoud Z; Malik RA; Anand A; Charalambous CP
JBJS Rev; 2020 Dec; 8(12):e20.00021. PubMed ID: 33347014
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 90-Day Adverse Events Associated With Aspirin and Potent Anticoagulation Use for Venous Thromboembolism Prophylaxis: A Cohort Study of 72,288 Total Knee and 35,142 Total Hip Arthroplasty Patients.
Singh G; Prentice HA; Winston BA; Kroger EW
J Arthroplasty; 2023 Aug; 38(8):1602-1612.e1. PubMed ID: 36805118
[TBL] [Abstract][Full Text] [Related]
3. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
Suen K; Westh RN; Churilov L; Hardidge AJ
J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
[TBL] [Abstract][Full Text] [Related]
4. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
5. The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials.
Meng J; Liu W; Xiao Y; Tang H; Wu Y; Gao S
Int J Surg; 2023 Nov; 109(11):3648-3655. PubMed ID: 37578443
[TBL] [Abstract][Full Text] [Related]
6. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
[TBL] [Abstract][Full Text] [Related]
7. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
Wilson DG; Poole WE; Chauhan SK; Rogers BA
Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
[TBL] [Abstract][Full Text] [Related]
9. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
10. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
[TBL] [Abstract][Full Text] [Related]
11. A risk-stratified approach to venous thromboembolism prophylaxis with aspirin or warfarin following total hip and knee arthroplasty: A cohort study.
Johnson SA; Jones AE; Young E; Jennings C; Simon K; Fleming RP; Witt DM
Thromb Res; 2021 Oct; 206():120-127. PubMed ID: 34455129
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
Richardson SS; Schairer WW; Sculco PK; Bostrom MP
Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
[TBL] [Abstract][Full Text] [Related]
13. Wound Discharge After Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty.
Jones CW; Spasojevic S; Goh G; Joseph Z; Wood DJ; Yates PJ
J Arthroplasty; 2018 Jan; 33(1):224-229. PubMed ID: 28869115
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
16. Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man.
Matharu GS; Garriga C; Whitehouse MR; Rangan A; Judge A
J Arthroplasty; 2020 Sep; 35(9):2631-2639.e6. PubMed ID: 32532481
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study.
Sidhu V; Badge H; Churches T; Maree Naylor J; Adie S; A Harris I
BMC Musculoskelet Disord; 2023 Aug; 24(1):629. PubMed ID: 37537580
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
[TBL] [Abstract][Full Text] [Related]
19. Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness.
Kahlenberg CA; Richardson SS; Schairer WW; Sculco PK
J Bone Joint Surg Am; 2018 Aug; 100(16):1366-1372. PubMed ID: 30106817
[TBL] [Abstract][Full Text] [Related]
20. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
